These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 6354071

  • 1. Combined short-term immunotherapy for experimental autoimmune myasthenia gravis.
    Pestronk A, Drachman DB, Teoh R, Adams RN.
    Ann Neurol; 1983 Aug; 14(2):235-41. PubMed ID: 6354071
    [Abstract] [Full Text] [Related]

  • 2. Treatment of ongoing experimental myasthenia gravis with short term high dose cyclophosphamide.
    Pestronk A, Drachman DB, Adams RN.
    Muscle Nerve; 1982 Jan; 5(1):79-84. PubMed ID: 6977088
    [Abstract] [Full Text] [Related]

  • 3. Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis.
    Okumura S, McIntosh K, Drachman DB.
    Ann Neurol; 1994 Nov; 36(5):704-13. PubMed ID: 7979216
    [Abstract] [Full Text] [Related]

  • 4. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis.
    Xiao BG, Duan RS, Zhu WH, Lu CZ.
    Cell Immunol; 2006 Jun; 241(2):95-101. PubMed ID: 17005165
    [Abstract] [Full Text] [Related]

  • 5. Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment.
    Im SH, Barchan D, Fuchs S, Souroujon MC.
    J Clin Invest; 1999 Dec; 104(12):1723-30. PubMed ID: 10606626
    [Abstract] [Full Text] [Related]

  • 6. Specific killing of lymphocytes that cause experimental autoimmune myasthenia gravis by ricin toxin-acetylcholine receptor conjugates.
    Killen JA, Lindstrom JM.
    J Immunol; 1984 Nov; 133(5):2549-53. PubMed ID: 6332854
    [Abstract] [Full Text] [Related]

  • 7. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells.
    Duan RS, Adikari SB, Huang YM, Link H, Xiao BG.
    Neurobiol Dis; 2004 Jul; 16(2):461-7. PubMed ID: 15193302
    [Abstract] [Full Text] [Related]

  • 8. Suppression of experimental myasthenia gravis by a B-cell epitope-free recombinant acetylcholine receptor.
    Yi HJ, Chae CS, So JS, Tzartos SJ, Souroujon MC, Fuchs S, Im SH.
    Mol Immunol; 2008 Nov; 46(1):192-201. PubMed ID: 18799218
    [Abstract] [Full Text] [Related]

  • 9. Single-fiber electromyography in experimental autoimmune myasthenia gravis.
    Verschuuren JJ, Spaans F, De Baets MH.
    Muscle Nerve; 1990 Jun; 13(6):485-92. PubMed ID: 2366822
    [Abstract] [Full Text] [Related]

  • 10. Monoclonal anti-acetylcholine receptor antibodies with differing capacities to induce experimental autoimmune myasthenia gravis.
    Gomez CM, Richman DP.
    J Immunol; 1985 Jul; 135(1):234-41. PubMed ID: 3873489
    [Abstract] [Full Text] [Related]

  • 11. T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY, Qiao J, Melms A, Link H.
    Cell Immunol; 1993 Dec; 152(2):394-404. PubMed ID: 8258147
    [Abstract] [Full Text] [Related]

  • 12. Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits.
    Levi G, Tarrab-Hazdai R, Teichberg VI.
    Eur J Immunol; 1983 Jun; 13(6):500-7. PubMed ID: 6861875
    [Abstract] [Full Text] [Related]

  • 13. Animal models of myasthenia gravis.
    Christadoss P, Poussin M, Deng C.
    Clin Immunol; 2000 Feb; 94(2):75-87. PubMed ID: 10637092
    [Abstract] [Full Text] [Related]

  • 14. Experimental autoimmune myasthenia gravis may occur in the context of a polarized Th1- or Th2-type immune response in rats.
    Saoudi A, Bernard I, Hoedemaekers A, Cautain B, Martinez K, Druet P, De Baets M, Guéry JC.
    J Immunol; 1999 Jun 15; 162(12):7189-97. PubMed ID: 10358165
    [Abstract] [Full Text] [Related]

  • 15. Lymphocyte responsiveness to acetylcholine receptor in rats with experimental autoimmune myasthenia gravis.
    Noguchi SA, Drachman DB, Adams RN, Hirsch RL.
    Ann Neurol; 1980 Jul 15; 8(1):32-7. PubMed ID: 7406445
    [Abstract] [Full Text] [Related]

  • 16. The role of B-cells in experimental myasthenia gravis in mice.
    Wang HB, Li H, He B, Bakheit M, Levi M, Wahren B, Berglöf A, Sandstedt K, Link H, Shi FD.
    Biomed Pharmacother; 1999 Jun 15; 53(5-6):227-33. PubMed ID: 10424244
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of experimental myasthenia gravis with total lymphoid irradiation.
    de Silva S, Blum JE, McIntosh KR, Order S, Drachman DB.
    Clin Immunol Immunopathol; 1988 Jul 15; 48(1):31-41. PubMed ID: 3260160
    [Abstract] [Full Text] [Related]

  • 20. Specificities of antibody to acetylcholine receptor in rabbits with experimental myasthenia gravis.
    Ueno S, Kang J, Takeuchi H, Takahashi M, Tarui S.
    Clin Exp Immunol; 1980 Jul 15; 41(1):13-8. PubMed ID: 6777100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.